Global Early Market Access Senior Manager

Fecha:  1 feb. 2024

About Almirall

We care. Through pharmaceutical innovation and a strong commitment to global healthcare partnerships, we are dedicated to providing the tools, knowledge and science to improve the health of patients worldwide. We research, develop, manufacture and market our own medicines as well as a portfolio of licensed products designed to respond to the needs of different therapeutic areas.  Today, our products are available in over 70 countries, on 5 continents, through 15 affiliates.  Find out how we work every day to help to transform lives through science.

How we work

Our strong values: Care, Courage, Innovation and Simplicity, are incorporated into everything we do, and they are behind our mission and vision which guide us today and lead us to the future.


The successful candidate will ensure that clinical, economic and societal perspectives are included in Almirall´s R&D approach. A key responsibility will be that market access requirements of key markets (EU and US) are addressed in pivotal trials. The scope includes molecules in development from pre-clinical up to and including phase IIIa. In addition, the successful candidate will be part of the team representing the Global Market Access department in R&D, the Portfolio review and New Product Planning activities. He/she will join a company with a diverse product pipeline and join a highly qualified Global Market Access team with stimulating professional challenges in a pleasant working atmosphere. The position is located at the company’s headquarters in Barcelona.

Tasks and Responsibilities

  • Represent Global Market Access in R&D, the Portfolio review and Product Planning activities.
  • Ensure payers’ perspectives and requirements are included in strategic R&D planning for products from pre-clinical development through completion of phase IIIa.
  • Defend the importance of the inclusion of market access criteria to internal decision makers and ensure potential trade-offs are considered.
  • Assess pricing potential and market access opportunities / risk for molecules in clinical development.
  • Develop mitigation plans for anticipated market access risks.
  • Create payer value messages and communication plans with relevant stakeholders.
  • Work together with internal & external stakeholders to identify key areas to develop future products.
  • Gather relevant market access information from key markets and competitors across dermatologic indications, including rare diseases and orphan drugs.
  • Keep updated and on top of trends and developments in pricing and reimbursement in key markets.
  • Lead payer research and ensure appropriate methodology is used.
  • Support the development of Market Access recommendations for selected business development opportunities (including market access scenarios, optimal clinical development, stakeholder engagement plan, and pricing).
  • Up to date with outcomes research and development of guidelines regarding Patient Reported Outcomes.
  • Support in building internal capabilities on conducting Early Scientific advice with HTAs and payers.


  • University degree in Pharmacy, Medicine, Biology, Economics or a comparable degree.
  • Master in Health Economics, Market Access, Business Administration or a comparable degree is desirable.

Experience and Competences

•    2-3 years of experience in Market Access and/or +5 years in business analytics / strategic consulting positions in an international environment in life sciences

•    Understanding of payer requirements from an evidence generation perspective. 

•    Capacity to manage several projects with competing priorities.

•    Ability to generate high quality project and strategic plans.

•    Analytical problem solver.

•    Excellent verbal and written communication skills.

As a global role, the position might require some travelling.


  • Care: we listen & empathize, we value diverse perspectives & backgrounds and we help each other succeed.
  • Courage: we challenge the status quo, we take full ownership and we learn from our success & failures
  • Innovation: we put the patient and customer at the center, we create novel solutions and we empower entrepreneurial mindsets. 
  • Simplicity: we act decisively and avoid over-analysis, we understand why before we act and we are agile & keep things simple.